TLIS logo

Talis Biomedical (TLIS) Company Overview

Profile

Full Name:

Talis Biomedical Corporation

Sector:

Healthcare

Country:

United States

IPO:

February 12, 2021

Indexes:

Not included

Description:

Talis Biomedical is a biotechnology company focused on developing rapid diagnostic tests for infectious diseases. Their innovative technology aims to provide quick and accurate results, helping healthcare providers make timely decisions. Talis is dedicated to improving patient care through advanced testing solutions.

Key Details

Price

$1.68

Annual Revenue

$412.00 K(-88.72% YoY)

Annual EPS

-$34.12(+45.64% YoY)

Annual ROE

-63.32%

Beta

0.53

Events Calendar

Earnings

Next earnings date:

May 8, 2025

Recent quarterly earnings:

Aug 10, 2024

Recent annual earnings:

Mar 22, 2023
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jul 6, 2023

Analyst ratings

Recent major analysts updates

Aug 16, 23 BTIG
Sell
Mar 18, 22 BTIG
Sell
Mar 16, 22 B of A Securities
Underperform
Jan 7, 22 B of A Securities
Underperform
Sep 27, 21 JP Morgan
Underweight
Aug 12, 21 Piper Sandler
Neutral
Aug 11, 21 JP Morgan
Neutral
Mar 9, 21 Piper Sandler
Overweight
Mar 9, 21 JP Morgan
Overweight
Mar 9, 21 BTIG
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Talis Biomedical?
  • Does Talis Biomedical pay dividends?
  • What sector is Talis Biomedical in?
  • What industry is Talis Biomedical in?
  • What country is Talis Biomedical based in?
  • When did Talis Biomedical go public?
  • Is Talis Biomedical in the S&P 500?
  • Is Talis Biomedical in the NASDAQ 100?
  • Is Talis Biomedical in the Dow Jones?
  • When was Talis Biomedical's last earnings report?
  • When does Talis Biomedical report earnings?
  • Should I buy Talis Biomedical stock now?

What is the ticker symbol for Talis Biomedical?

The ticker symbol for Talis Biomedical is NASDAQ:TLIS

Does Talis Biomedical pay dividends?

No, Talis Biomedical does not pay dividends

What sector is Talis Biomedical in?

Talis Biomedical is in the Healthcare sector

What industry is Talis Biomedical in?

Talis Biomedical is in the Medical Devices industry

What country is Talis Biomedical based in?

Talis Biomedical is headquartered in United States

When did Talis Biomedical go public?

Talis Biomedical's initial public offering (IPO) was on February 12, 2021

Is Talis Biomedical in the S&P 500?

No, Talis Biomedical is not included in the S&P 500 index

Is Talis Biomedical in the NASDAQ 100?

No, Talis Biomedical is not included in the NASDAQ 100 index

Is Talis Biomedical in the Dow Jones?

No, Talis Biomedical is not included in the Dow Jones index

When was Talis Biomedical's last earnings report?

Talis Biomedical's most recent earnings report was on Aug 10, 2024

When does Talis Biomedical report earnings?

The next expected earnings date for Talis Biomedical is May 8, 2025

Should I buy Talis Biomedical stock now?

As of today, analysts generally recommend a 'Strong sell' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions